Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: AIDS Behav. 2017 Aug;21(8):2439–2451. doi: 10.1007/s10461-016-1503-x

Table 4.

Participant and Partner Characteristics and Condomless Anal Intercourse with the Last Three Non-Female Sexual Partners of TW, Lima, Peru, 2012–2014

Participant-Level Characteristics Insertive AI (N=48)
Receptive AI (N=133)
Condomless (N=15)* Condomless (N=32)*
Age median (IQR) 28 (22–34) 27.5 (22.5–31.5)
Education
    Less than Secondary 8 (36.4) 11 (25.6)
    Secondary 3 (20.0) 12 (23.1)
    University/Technical School 4 (36.4) 9 (24.3)
HIV Status a
    Infected 5 (18.5) 17 (27.4)
    Uninfected 9 (56.3) 11 (18.0)
    Unknown 1 (20.0) 4 (40.0)
Recent STIs b
    Yes 8 (30.8) 15 (25.9)
    No 5 (31.3) 13 (21.7)
    Unsure 1 (25.0) 1 (20.0)
Sexual Role
    Activa 0 (0.0) 0 (0.0)
    Pasiva 6 (24.0) 26 (26.8)
    Moderna 9 (45.0) 6 (19.3)
Sexual Role Strain c
    Yes 6 (22.2) 5 (17.2)
    No 0 (0.0) 21 (28.8)
Alcohol Use Disorders (AUD) d
    No AUD 4 (26.7) 12 (25.5)
    Hazardous Use 7 (36.8) 11 (22.0)
    Harmful Use 2 (50.0) 5 (27.8)
    Dependent Use 2 (20.0) 4 (23.5)

Partner-Level Characteristics and
TW Sexual Practices e
Insertive AI (N=95)
Receptive AI (N=355)
Condomless (N=40)* Condomless (N=137)*

Partner Type
    Primary 9 (29.0) 59 (44.7)
    Casual 14 (42.4) 49 (36.6)
    Transactional Sex 17 (54.8) 29 (32.6)
Gender
    Men 33 (43.4) 127 (39.3)
    Transgender 7 (36.8) 10 (31.2)
Sexual Orientation/Gender Identity
    Heterosexual 3 (16.7) 45 (36.0)
    Bisexual 17 (53.1) 65 (40.9)
    Homosexual 6 (25.0) 11 (30.6)
    Transgender f 2 (50.0) 4 (44.4)
    Other 8 (88.9) 5 (45.4)
Sexual Role
    Activo 11 (32.3) 108 (39.7)
    Pasivo 3 (21.4) 6 (31.6)
    Moderno 24 (55.8) 21 (38.9)
    Other g 0 (0.0) 1 (50.0)
HIV Status
    Infected 2 (16.7) 7 (30.4)
    Uninfected 1 (10.0) 13 (23.6)
    Unknown 37 (50.7) 117 (42.2)
Participant Alcohol Use Before Sex
    Yes 18 (50.0) 46 (47.9)
    No 22 (38.6) 88 (35.2)
    Unsure 0 (0.0) 3 (33.3)
Participant Drugs Use Before Sex
    Yes 9 (42.9) 119 (38.6)
    No 30 (41.7) 17 (41.5)
    Unsure 1 (50.0) 1 (16.7)
*

Figures for condom-protected AI not shown, as they are the complement of the condomless AI figures.

N denotes total number of participants engaging in type of AI.

N denotes total number of partners with which TW engage in type of AI.

a

Self-reported

b

Reported receiving diagnosis within last 30 days of at least one bacterial STI or ever diagnosed with a viral STI. STIs included: syphilis, gonorrhea, chlamydia, genital ulcers, genital herpes, genital warts, urethritis, proctitis, UTI.

c

Restricted to activa/pasiva-identified TW (n=104). Strain= practicing a type of AI that does not match the preferred activa/pasiva role. No strain = practicing the type of AI that matches the preferred activa/pasiva role.

d

Categories based on internationally-validated WHO AUDIT guidelines

e

As perceived and reported by TW participants

f

Transgender” was provided as an option for sexual orientation/gender identity. The numbers do not match that for the partner gender variable due to presence of other options for classifying partner sexual behaviors.

g

“Other” qualitative responses included: macho, bisexual